Morepen Laboratories Ltd. — Investor Relations & Filings
Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Newspaper Publication- Q4 and FY 26 Financial Results | 2026-05-27 | English | |
| Copy of Newspaper Publication | 2026-05-27 | English | |
| Please find enclosed Investor Presentation on Q4 & FY26 Results | 2026-05-27 | English | |
| Please find enclosed press release | 2026-05-27 | English | |
| Press Release | 2026-05-27 | English | |
| Investor Presentation | 2026-05-27 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47226253 | Newspaper Publication- Q4 and FY 26 Financial Results | 2026-05-27 | English | ||
| 47199060 | Copy of Newspaper Publication | 2026-05-27 | English | ||
| 47098765 | Please find enclosed Investor Presentation on Q4 & FY26 Results | 2026-05-27 | English | ||
| 47098769 | Please find enclosed press release | 2026-05-27 | English | ||
| 47099100 | Press Release | 2026-05-27 | English | ||
| 47099097 | Investor Presentation | 2026-05-27 | English | ||
| 47062681 | Re-appointment of Cost Auditors of the Company | 2026-05-26 | English | ||
| 47061631 | Please find attached the file | 2026-05-26 | English | ||
| 47061666 | Please find attached the file | 2026-05-26 | English | ||
| 47061721 | Please find attached the file | 2026-05-26 | English | ||
| 47061729 | Appointment | 2026-05-26 | English | ||
| 47061726 | Dividend | 2026-05-26 | English | ||
| 47061722 | Outcome of Board Meeting | 2026-05-26 | English | ||
| 47061719 | Amendment(s) | 2026-05-26 | English | ||
| 47061814 | Please find attached outcome of Board meeting | 2026-05-26 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Morepen Laboratories Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/59389/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=59389 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=59389 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=59389 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 59389}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Morepen Laboratories Ltd. (id: 59389)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.